# FDA 483 - La Crosse Milling Co. - November 18, 2024

Source: https://www.globalkeysolutions.net/records/483/la-crosse-milling-co/ae772af7-4aeb-4f28-93b9-ca7024f41a1f

> FDA 483 for La Crosse Milling Co. on November 18, 2024. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: La Crosse Milling Co.
- Inspection Date: 2024-11-18
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - West I
- Summary: La Crosse Milling Co. in Cochrane, WI, an API manufacturer, received a Form 483 with five observations during an inspection from November 18-22, 2024. The observations primarily concern significant deficiencies in quality unit responsibilities, process and cleaning validation, label control, and batch production record documentation, indicating a lack of robust quality system controls.

## Related Officers

- [Consumer Safety Officer/ Federal Investigator](https://www.globalkeysolutions.net/people/lisa-l-flores/465a6807-55d7-4c3f-a415-c21ac4517bc9)
- [Travis V. Hull](https://www.globalkeysolutions.net/people/travis-v-hull/1f3b5843-29ed-4291-8a8a-a2bf3ac36988)

Company: https://www.globalkeysolutions.net/companies/la-crosse-milling-co/5f2c8229-ee30-4508-8b49-84f0a6d926f9

Office: https://www.globalkeysolutions.net/offices/division-of-human-and-animal-food-operations-west-i/1c3129a0-b8fd-4558-9283-44531498dbdd
